Glioblastoma (GBM) is the most common primary malignant brain tumor of adults and confers a poor prognosis due， in part， to diffuse invasion of tumor cells. Heparan sulfate (HS) glycosaminoglycans， present on the cell surface and in the extracellular matrix， regulate cell signaling pathways and cell-microenvironment interactions. In GBM， the expression of HS glycosaminoglycans and the enzymes that regulate their function are altered， but the actual HS content and structure are unknown. However， inhibition of HS glycosaminoglycan function is emerging as a promising therapeutic strategy for some cancers. In this study， we use liquid chromatography-mass spectrometry analysis to demonstrate differen... More
Glioblastoma (GBM) is the most common primary malignant brain tumor of adults and confers a poor prognosis due， in part， to diffuse invasion of tumor cells. Heparan sulfate (HS) glycosaminoglycans， present on the cell surface and in the extracellular matrix， regulate cell signaling pathways and cell-microenvironment interactions. In GBM， the expression of HS glycosaminoglycans and the enzymes that regulate their function are altered， but the actual HS content and structure are unknown. However， inhibition of HS glycosaminoglycan function is emerging as a promising therapeutic strategy for some cancers. In this study， we use liquid chromatography-mass spectrometry analysis to demonstrate differences in HS disaccharide content and structure across four patient-derived tumorsphere lines (GBM1， 5， 6， 43) and between two murine tumorsphere lines derived from murine GBM with enrichment of mesenchymal and proneural gene expression (mMES and mPN， respectively) markers. In GBM， the heterogeneous HS content and structure across patient-derived tumorsphere lines suggested diverse functions in the GBM tumor microenvironment. In GBM5 and mPN， elevated expression of sulfatase 2 (SULF2)， an extracellular enzyme that alters ligand binding to HS， was associated with low trisulfated HS disaccharides， a substrate of SULF2. In contrast， other primary tumorsphere lines had elevated expression of the HS-modifying enzyme heparanase (HPSE). Using gene editing strategies to inhibit HPSE， a role for HPSE in promoting tumor cell adhesion and invasion was identified. These studies characterize the heterogeneity in HS glycosaminoglycan content and structure across GBM and reveal their role in tumor cell invasion. HS-interacting factors promote GBM invasion and are potential therapeutic targets. .
